Immunology, Transplantation, Internal medicine, Hematopoietic stem cell transplantation and Surgery are his primary areas of study. His Immunology study integrates concerns from other disciplines, such as Mesenchymal stem cell, Cytotoxic T cell and Haematopoiesis, Stem cell. Franco Locatelli has researched Transplantation in several fields, including Survival rate, Transplantation Conditioning, Leukemia and Bone marrow.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology. His research integrates issues of T cell, CD34, Total body irradiation, Human cytomegalovirus and Innate immune system in his study of Hematopoietic stem cell transplantation. His work deals with themes such as Thalassemia, Incidence, Cumulative incidence, Anemia and Disease, which intersect with Surgery.
Franco Locatelli spends much of his time researching Internal medicine, Immunology, Hematopoietic stem cell transplantation, Transplantation and Cancer research. Franco Locatelli combines subjects such as Gastroenterology, Surgery and Oncology with his study of Internal medicine. His studies in Immunology integrate themes in fields like Cytotoxic T cell and Haematopoiesis.
His study in Hematopoietic stem cell transplantation is interdisciplinary in nature, drawing from both Incidence, Cumulative incidence, Acute lymphocytic leukemia, Pediatrics and Acute leukemia. The study incorporates disciplines such as Stem cell, Fludarabine and Disease in addition to Transplantation. His biological study spans a wide range of topics, including Immunophenotyping and Mesenchymal stem cell.
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer research, Hematopoietic stem cell transplantation and Immunology. His work on Gastroenterology expands to the thematically related Internal medicine. Within one scientific family, he focuses on topics pertaining to Chimeric antigen receptor under Cancer research, and may sometimes address concerns connected to Cell therapy.
The various areas that Franco Locatelli examines in his Hematopoietic stem cell transplantation study include Hemophagocytic lymphohistiocytosis, Receptor, Human leukocyte antigen and Cumulative incidence. The concepts of his Immunology study are interwoven with issues in Haematopoiesis and Disease. In his study, Bone marrow is strongly linked to Stem cell, which falls under the umbrella field of Transplantation.
His main research concerns Internal medicine, Cancer research, Hematopoietic stem cell transplantation, Immunology and Disease. His Internal medicine research includes themes of Gastroenterology and Oncology. His Cancer research research integrates issues from Natural killer cell, Chimeric antigen receptor, Immunotherapy and SMARCA4.
Hematopoietic stem cell transplantation is the subject of his research, which falls under Transplantation. His Transplantation research incorporates elements of Hematopoietic cell, Stem cell and Pediatrics. His studies deal with areas such as Progenitor cell, Thalassemia and Severe acute respiratory syndrome coronavirus 2 as well as Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
Katarina Le Blanc;Francesco Frassoni;Lynne Ball;Franco Locatelli.
The Lancet (2008)
Outcome of cord-blood transplantation from related and unrelated donors
Eliane Gluckman;Vanderson Rocha;Agnes Boyer-Chammard;Franco Locatelli.
The New England Journal of Medicine (1997)
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
Vanderson Rocha;Jacqueline Cornish;Eric L. Sievers;Alexandra Filipovich.
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
Maria Ester Bernardo;Nadia Zaffaroni;Francesca Novara;Angela Maria Cometa.
Cancer Research (2007)
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype
Rita Maccario;Marina Podestà;Antonia Moretta;Angela Cometa.
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter;Claus R. Bartram;Maria Grazia Valsecchi;Andre Schrauder.
Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.
Lynne M. Ball;Maria Ester Bernardo;Helene Roelofs;Arjan Lankester.
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
Sebastian Giebel;Franco W Locatelli;Teresa Lamparelli;Andrea Velardi.
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
Rachele Ciccocioppo;Maria Ester Bernardo;Adele Sgarella;Rita Maccario.
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
R de Marco;F Locatelli;G Zoppini;G Verlato.
Diabetes Care (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: